Clinical Trials on Disorders of Synovium, Multiple Sites
Total 26275 results
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedArthritis, Rheumatoid | Healthy People | Disorders of Synovium, Multiple Sites | Disorders of Subchondral Bone, Multiple Sites | Disorders of Cartilage, Hand Joints
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple Sites
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingMalignant Neoplasms of Independent (Primary) Multiple Sites | Benign NeoplasmsUnited States
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
Ufuk UniversityCompletedPain in A Joint, Multiple SitesTurkey
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
Tel Aviv UniversityNot yet recruitingMultiple Injuries of Hand (Disorder)
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple Sites | Benign Neoplasms | In Situ NeoplasmsUnited States
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
University Hospital, Gentofte, CopenhagenCompletedMultiple Chemical SensitivitiesDenmark
-
Sohag UniversityNot yet recruitingMultiple Fractures of Ribs
-
University of California, DavisBayerCompletedWounds and Injuries | Multiple Trauma | Disorder of Fluid BalanceUnited States
-
University of FloridaCompletedStability of Attentional Networks Over Multiple Sessions of Computerized TaskUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsTerminatedDepression | Relapsing-remitting Multiple SclerosisGermany
-
Icahn School of Medicine at Mount SinaiWithdrawnRelapsing-remitting Multiple Sclerosis (RRMS)United States
-
UMC UtrechtTerminatedSepsis | Multiple Trauma | Innate Immune Response | Multiple Organ Dysfunction Syndrome | Disorder of NeutrophilsNetherlands
-
Assiut UniversityAl-Azhar UniversityEnrolling by invitationRole of Neurofilment in Diagnosis of Multiple SclerosisEgypt
-
Suleyman Demirel UniversityCompletedOral Findings in Children of Multiple and Single Births | Radiographic Evaluation of Oral Findings in Children of Multiple and Single BirthsTurkey
-
Assaf-Harofeh Medical CenterUnknownRemoval of Colors Tattoo (Multiple Colors)Israel
-
Isfahan University of Medical SciencesCompletedClosed Multiple Fractures of Upper and Lower Limbs
-
Merck KGaA, Darmstadt, GermanyMerck Quimica Argentina S.A.I.CCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
The Danish Research Centre for Chemical SensitivitiesAage Bangs FondCompletedMultiple Chemical SensitivityDenmark
-
University of KansasFutures Without ViolenceUnknownDomestic Violence | Multiple Forms of Child AbuseUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-remittingArgentina
-
University of PennsylvaniaParker Institute for Cancer Immunotherapy; Tmunity TherapeuticsTerminatedMelanoma | Multiple Myeloma | Myxoid/Round Cell Liposarcoma | Synovial SarcomaUnited States
-
Roessingh Research and DevelopmentEurostarsNot yet recruitingNeurologic Disorder | Trauma Injury of Hand Multiple
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)Czech Republic, Switzerland
-
University of Eastern FinlandCompletedQuality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple SclerosisFinland
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis | Relapsing Forms of Multiple Sclerosis
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Relapsing-RemittingSweden, Germany
-
Istituto Ortopedico GaleazziCompletedIL-6 Concentration in the Synovial Fluid of Obese Patients is 100% Higher Than the IL-6 Concentration of the Synovial Fluid in Normal Weight PatientsItaly
-
The Danish Research Centre for Chemical SensitivitiesCompletedMultiple Chemical SensitivityDenmark
-
Harpoon TherapeuticsActive, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma of BoneUnited States, Spain, France
-
Somogy Megyei Kaposi Mór Teaching HospitalUniversity Medical Center GroningenCompletedMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Primary ProgressiveHungary
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
University of Colorado, DenverCompleted
-
University Hospital of Mont-GodinneUniversité Catholique de Louvain; Teva Pharmaceuticals USATerminatedRelapsing Remitting Multiple Sclerosis | Motor Deficits | Cognitive Deficits | Secondary-progressive Multiple SclerosisBelgium
-
University of AarhusEnrolling by invitationBodily Distress Syndrome | Functional Disorder | Multiple Chemical SensitivityDenmark
-
Memorial Sloan Kettering Cancer CenterCompletedSynovial Sarcoma | Single or Multiple Lung MetastasesUnited States
-
Epizyme, Inc.CompletedSynovial Sarcoma | INI1-negative Tumors | Malignant Rhabdoid Tumor of Ovary | Rhabdoid TumorsUnited States, France, Canada, Italy, Germany, United Kingdom, Australia, Denmark, Netherlands
-
Cai LiUnknownInjury of Other and Multiple Parts of Small IntestineChina
-
University of Missouri-ColumbiaNational Institute on Aging (NIA)Active, not recruitingReducing COVID-19 Related Disability in Rural Community-Dwelling Older Adults Using Smart TechnologyQuality of Life | Disabilities MultipleUnited States
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)France
-
Universitätsklinikum Hamburg-EppendorfNeovii Biotech; Clinical Trial Center North (CTC North GmbH & Co. KG)TerminatedRelapsing-Remitting Multiple SclerosisGermany
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisCanada
-
BayerCompletedRelapsing-remitting Multiple SclerosisFrance